NEWS

WHO slow to approve COVID jab developed in India without using aborted fetal cell lines

Updated: October 18, 2021 at 5:57 pm EST  See Comments

Mon Oct 18, 2021 – 5:41 pm EDT

LifeSiteNews has produced an extensive COVID-19 vaccines resources page. View it here. 

(LifeSiteNews) – A COVID jab developed without using an aborted fetal cell line has been created in India.  

Covaxin is an inactivated, virus-based vaccine developed by Bharat Biotech’s cell manufacturing platform in conjunction with the Indian Council of Medical Research. Vero cells are a lineage of cells used in cell cultures developed in Japan in 1962 from isolated kidney epithelial cells taken from a species of monkey known as the “African green monkey.” 

The fact that the medication was developed based on an animal cell line could be considered positive news for pro-lifers who want to avoid cooperation with a product or industry that uses terminated infants for research. So far, it is not clear whether Covaxin has used aborted fetal cell lines in testing.  

Although Covaxin is approved in a variety of countries for use, the World Health Organization (WHO) said it “cannot cut corners” regarding Covaxin and is still reviewing the drug for safety.  

The WHO has approved a number of other COVID shots, all of which contain cell lines from abortion in testing or development.  

The AstraZeneca vaccine rollout was stopped in many regions, including Denmark, due to significant risks

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors

LEAVE A REPLY

Please enter your comment!
Please enter your name here

A Quick Note…

Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Christian Journal and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.